fda d.i.s.c.o. burst edition: fda approval of retevmo (selpercatinib) for advanced or metastatic ...
Published 1 month ago • 1.7K plays • Length 4:01Download video MP4
Download video MP3
Similar videos
-
6:31
fda d.i.s.c.o. burst edition: fda approvals of retevmo (selpercatinib) for adult patients with lo...
-
4:01
fda d.i.s.c.o. burst edition: lorbrena (lorlatinib) for patients with metastatic non-small cell l...
-
4:01
fda d.i.s.c.o. burst edition: fda approves a new dosing regimen for asparaginase erwinia chrysant...
-
6:01
fda d.i.s.c.o.: osimertinib for non-small cell lung cancer
-
57:12
targeted therapies (i.e.: multi-kinase inhibitors, ret, ntrk inhibitors) in advanced disease. 251
-
5:52
patient video explains radioiodine
-
56:55
the abcs of dtc & variants: understanding key terms, concepts & initial diagnostic & treatment. 154
-
2:38
fda approved lilly's retevmo (selpercatinib) a new treatment of advanced lung and thyroid cancers
-
7:02
fda approval of selpercatinib for ret fusion positive nsclc and thyroid cancers
-
0:46
fda approves capmatinib for advanced lung cancer
-
3:46
us fda approves rybrevant (amivantamab) lazcluze (lazertinib) for non-small cell lung cancer
-
7:35
fda approval for abemaciclib
-
6:01
fda d.i.s.c.o.: osimertinib for non-small cell lung cancer
-
9:00
fda d.i.s.c.o.: two approvals for alk-positive non-small cell lung cancer
-
3:01
new fda approved treatment for lung cancer (fcl july 2nd 2020)
-
7:21
fda approval of ribociclib for metastatic breast cancer
-
0:59
selpercatinib approved for treatment of tumours harbouring ret gene fusions #cancer #selpercatinib
-
4:04
retevmo (selpercatinib) - drug rx information
-
21:16
precision medicine advances in thyroid cancer – management of advanced rai refractory
-
10:41
fda approvals in ovarian cancer and for mec chemo, promising data in lung cancer, and more
-
9:47
sorafenib in advanced dtc